Wellington Shields & Co., LLC
- SEC CIK
- 0001506073
- Latest filing
- Aug 10, 2026
GSK holding history
GSK plc in every 13F filed by Wellington Shields & Co., LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
GSK overviewAll 13F holders of GSKFull Q2 2026 holdings
- Shares (Q2 2026)
- 1,384
- Value
- $72.5K
- % of portfolio
- <0.1%
- Quarters held
- 19
- Since Q1 2021
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q2 2026 | 1,384 | $72.5K | <0.1% | −59−4.1% | Reduced | Holders |
| Q1 2026 | 1,443 | $79.6K | <0.1% | 00.0% | Unchanged | Holders |
| Q4 2025 | 1,443 | $70.8K | <0.1% | −264−15.5% | Reduced | Holders |
| Q3 2025 | 1,707 | $73.7K | <0.1% | +1,707 | New | Holders |
| Q4 2024 | 0 | $0 | 0.0% | −2,379−100.0% | Sold out | Holders |
| Q3 2024 | 2,379 | $97.3K | <0.1% | 00.0% | Unchanged | Holders |
| Q2 2024 | 2,379 | $91.6K | <0.1% | 00.0% | Unchanged | Holders |
| Q1 2024 | 2,379 | $102.0K | <0.1% | 00.0% | Unchanged | Holders |
| Q4 2023 | 2,379 | $88.2K | <0.1% | −880−27.0% | Reduced | Holders |
| Q3 2023 | 3,259 | $118.1K | <0.1% | −1,066−24.6% | Reduced | Holders |
| Q2 2023 | 4,325 | $154.1K | <0.1% | 00.0% | Unchanged | Holders |
| Q1 2023 | 4,325 | $153.9K | <0.1% | +59+1.4% | Added | Holders |
| Q4 2022 | 4,266 | $149.9K | <0.1% | 00.0% | Unchanged | Holders |
| Q3 2022 | 4,266 | $126.0K | 0.1% | −1,067−20.0% | Reduced | Holders |
| Q2 2022 | 5,333 | $232.0K | 0.1% | −2,200−29.2% | Reduced | Holders |
| Q1 2022 | 7,533 | $328.0K | 0.1% | +1,000+15.3% | Added | Holders |
| Q4 2021 | 6,533 | $288.0K | 0.1% | −800−10.9% | Reduced | Holders |
| Q3 2021 | 7,333 | $280.0K | 0.1% | +500+7.3% | Added | Holders |
| Q2 2021 | 6,833 | $272.0K | 0.1% | 00.0% | Unchanged | Holders |
| Q1 2021 | 6,833 | $244.0K | 0.1% | – | – | Holders |
Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.